Bladder cancer Board decisions

The Veteran's appeal to reduce his bladder cancer rating from 100% to 40% effective November 1, 2023 has been dismissed due to the appellant's withdrawal of the appeal.

The Board denied service connection for diabetes mellitus, bladder cancer, and prostate cancer prior to August 10, 2022 on the basis of direct herbicide exposure. The evidence did not support such a finding.

The Veteran's death is due to his service-connected bladder cancer, which was caused by his in-service exposure to herbicide agents like Agent Orange. As a result, the Board has granted entitlement to service connection for the cause of the Veteran's death.

The Board has remanded the claims of service connection for throat cancer, bladder cancer, and skin cancer of the face and chest due to a duty to assist error. A VA examination is needed to assess whether these cancers are related to exposure to mustard gas during service.

The Board has granted service connection for deep vein thrombosis as secondary to the Veteran's service-connected bladder cancer.

The Board has denied service connection for bladder cancer, heart condition, hypothyroidism, migratory inflammatory arthritis of the elbows, wrists, fingers, thumbs, hips, and knees, as well as left and right shoulder conditions due to lack of evidence linking these conditions to active service.,Service connection was not granted because there is no medical evidence showing that any of the claimed conditions were incurred or aggravated during military service.

Your claim for service connection for bladder cancer has been fully granted, effective October 24, 2018. The appeal is dismissed as the issue is no longer pending.

The Veteran's TDIU is denied as he did not meet the schedular requirements for a TDIU prior to January 1, 2021. The effective date of the award of SMC based on statutory housebound criteria is granted.,The Veteran does not have any service-connected conditions that qualify under the PACT Act, Agent Orange, Camp Lejeune, or radiation exposure.

The Veteran's TDIU claim is granted with an effective date of October 26, 2016. The period from October 26, 2016 through December 31, 2016 is excluded due to the mootness of the TDIU during this period.

The Board has remanded the claims for sigmoid colon cancer and bladder cancer due to insufficient reasons or bases provided in the previous decisions. The Appellant requested additional evidence, which was submitted and considered.

The Board has remanded the claim for service connection for bladder pheochromocytoma and/or bladder cancer due to inadequate VA examinations, lack of clarity in medical evidence, and need for a new examination.

The Veteran's claim for a compensable rating for bladder cancer from January 1, 2017 to May 5, 2017 is denied as there is no evidence of current bladder cancer or its residuals during this period.

The Veteran's service-connected disabilities, including unspecified trauma and stressor related disorder with a depressive disorder, residuals of bladder cancer, bilateral hearing loss, and tinnitus, have rendered him unemployable since October 21, 2019. The Board has granted TDIU effective from that date.

The Board denied the Veteran's claims for an initial rating in excess of 10 percent for bladder cancer residuals and continuance of a 100 percent disability rating for service-connected bladder cancer status post transurethral resection of the bladder tumor, finding that the evidence did not support these ratings from June 22, 2023.

The Board has found a duty to assist error in the August 2023 rating decision and has remanded the case for further examination and opinion regarding the Veteran's service-connected disabilities and their impact on his ability to work.

The Veteran's service connection claims for DMII, prostate cancer, bladder cancer, multiple myeloma, and hypertension have been granted. The heart condition claim is remanded due to a duty-to-assist error.

The Veteran's claim for service connection for the cause of his death has been dismissed as he was granted service connection in a May 2022 rating decision.,The Veteran's claim for service connection for bladder cancer/lymph nodes associated with prostate cancer, status post prostatectomy, has also been dismissed. The AOJ granted service connection based on herbicide exposure and assigned a 100 percent rating effective March 7, 2014.

The Board has denied the Veteran's claims for service connection for Bladder Cancer and Abdominal Aortic Aneurysm. The case is being remanded to determine if his acquired psychiatric condition, erectile dysfunction, or sleep apnea are related to his active duty service.,If any of these conditions are found to be service connected, the Board will also consider whether they are aggravated by his service-connected acquired psychiatric disorder.

The Board has granted service connection for bladder cancer and its residuals, finding that the Veteran's exposure to herbicide agents during his service in or near the Korean DMZ qualifies him for presumptive service connection.

The Board has denied service connection for lung cancer and bladder cancer, finding that the evidence does not support a direct relationship to active duty service.